Susan Eylward
CIK: 0002039135
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Imunon, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 31, 2026IMNN
Imunon, Inc.
Sale(S)Direct2.5K shares at avg. $1.56$4K - Aug 28, 2026IMNN
Imunon, Inc.
Award(A)Direct2.5K shares at avg. $1.60$4K - Aug 17, 2026IMNN
Imunon, Inc.
Sale(S)Direct2.4K shares at avg. $1.63$4K - Aug 14, 2026IMNN
Imunon, Inc.
Award(A)Direct2.4K shares at avg. $1.65$4K - Aug 3, 2026IMNN
Imunon, Inc.
Sale(S)Direct2.5K shares at avg. $1.57$4K - Jul 31, 2026IMNN
Imunon, Inc.
Award(A)Direct2.5K shares at avg. $1.59$4K - Jul 20, 2026IMNN
Imunon, Inc.
Sale(S)Direct2.2K shares at avg. $1.78$4K - Jul 17, 2026IMNN
Imunon, Inc.
Award(A)Direct2.2K shares at avg. $1.83$4K - Jul 6, 2026IMNN
Imunon, Inc.
Sale(S)Direct920 shares at avg. $1.88$2K - Jul 2, 2026IMNN
Imunon, Inc.
Award(A)Direct920 shares at avg. $1.91$2K - Jun 29, 2026IMNN
Imunon, Inc.
Sale(S)Direct11.8K shares at avg. $1.75$21K - Jun 25, 2026IMNN
Imunon, Inc.
Award(A)Direct14.7K shares at avg. $1.72$25K - Jan 2, 2026IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
8.3K shares- - Aug 4, 2025IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
417 shares- - Mar 14, 2025IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
6.3K shares- - Oct 7, 2024IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 | IMNN Imunon, Inc. | Sale(S) | 2,525 | $1.56 | $3,950 | Direct |
| Aug 28, 2026 | IMNN Imunon, Inc. | Award(A) | 2,525 | $1.60 | $4,040 | Direct |
| Aug 17, 2026 | IMNN Imunon, Inc. | Sale(S) | 2,449 | $1.63 | $3,993 | Direct |
| Aug 14, 2026 | IMNN Imunon, Inc. | Award(A) | 2,449 | $1.65 | $4,041 | Direct |
| Aug 3, 2026 | IMNN Imunon, Inc. | Sale(S) | 2,541 | $1.57 | $3,977 | Direct |
| Jul 31, 2026 | IMNN Imunon, Inc. | Award(A) | 2,541 | $1.59 | $4,040 | Direct |
| Jul 20, 2026 | IMNN Imunon, Inc. | Sale(S) | 2,150 | $1.78 | $3,830 | Direct |
| Jul 17, 2026 | IMNN Imunon, Inc. | Award(A) | 2,150 | $1.83 | $3,935 | Direct |
| Jul 6, 2026 | IMNN Imunon, Inc. | Sale(S) | 920 | $1.88 | $1,730 | Direct |
| Jul 2, 2026 | IMNN Imunon, Inc. | Award(A) | 920 | $1.91 | $1,757 | Direct |
| Jun 29, 2026 | IMNN Imunon, Inc. | Sale(S) | 11,800 | $1.75 | $20,674 | Direct |
| Jun 25, 2026 | IMNN Imunon, Inc. | Award(A) | 14,696 | $1.72 | $25,277 | Direct |
| Jan 2, 2026 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 8,251 | - | - | Direct |
| Aug 4, 2025 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 417 | - | - | Direct |
| Mar 14, 2025 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 6,250 | - | - | Direct |
| Oct 7, 2024 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 50,000 | - | - | Direct |
1-16 of 16 transactions
About Eylward Susan
Eylward Susan (SEC CIK 0002039135) files insider reports with the SEC as General Counsel and Corp Sec of Imunon, Inc. (IMNN).
Signal8 holds 11 ownership filings by Eylward Susan (1 Form 3, 10 Form 4), filed between Oct 7, 2024 and Sep 1, 2026. Those filings report 16 transactions, from Oct 7, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eylward Susan's filings is in LAWRENCEVILLE, NJ.
Recent filings by Eylward Susan
- Aug 31, 2026: Open-market sale of IMNN shares (Form 4, code S).
- Aug 28, 2026: Grant or award of IMNN shares (Form 4, code A).
- Aug 17, 2026: Open-market sale of IMNN shares (Form 4, code S).
- Aug 14, 2026: Grant or award of IMNN shares (Form 4, code A).
- Aug 3, 2026: Open-market sale of IMNN shares (Form 4, code S).
Other insiders filing for Imunon, Inc. (IMNN)
- Tardugno Michael H, Executive Chairman of Board
- Lindborg Stacy, President and CEO
- Faller Douglas Vincent, Chief Medical Officer
- Pellizzari Christine A, Director
- Dentzer James E, Director
- Fritz Frederick J., Director